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Abstract
Streptococcal toxic shock syndrome and associated myositis caused by group A beta-hemolytic
streptococcus pyogenes generally have a poor outcome despite aggressive operative treatment.
Frequently the diagnosis is missed initially as the clinical features are non-specific. The progression
to a toxic state is rapid and unless definitive treatment measures are initiated early, the end result
can be catastrophic. We report a previously healthy patient who had features of toxic shock
syndrome due to alpha haemolytic (viridans) streptococcus mitis which was treated successfully
with antibiotics, aggressive intensive care support including the use of a 'sepsis care bundle',
monitoring and continuous multidisciplinary review. Life and limb threatening emergencies due to
streptococcus mitis in an immune-competent person are rare and to our knowledge, have not
previously been described in the English scientific literature. Successful outcome is possible
provided a high degree of suspicion is maintained and the patient is intensively monitored.
Case presentation
A previously healthy 33 year old woman was admitted to
the acute medical care unit with a two day history of feel-
ing lethargic and unwell. She was a non smoker and did
not drink alcohol. She had developed severe continuous
pain in the right upper limb with no specific aggravating
or relieving factors and associated with severe weakness.
She had had three episodes of vomiting and diarrhoea
and had been treated by her general practitioner with
paracetamol for flu-like symptoms for three days. On the
morning of the day of admission she had noticed that her
lips and tongue were swollen and she felt short of breath.
She was given intramuscular adrenaline by the ambulance
staff for a threatened airway and was transferred to the
acute medical unit for further evaluation and manage-
ment.
On admission she had pulse rate of 110/min, respiratory
rate of 22/min and was febrile with a temperature of 38.9
deg c. She was agitated, restless and incontinent. Three
hours later she started to develop swelling of the face. The
facial skin was intact and there was no erythema, rash or
blisters. Examination of the oral cavity revealed an oede-
matous tongue, pharynx and buccal mucosa with no
detectable septic focus. There was no neck stiffness, no
localising neurological signs and her GCS was 14. There
was no local rise of temperature and soft tissue palpation
of the head and neck was normal with no localised tender-
ness and no palpable lymph nodes or surgical emphy-
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sema. Air entry was equal on both sides but there were
diffusely scattered rhonchi. Cardiovascular system exami-
nation was normal. Abdominal examination revealed a
localised tenderness in the left iliac fossa. Pelvic and peri-
neal examination by the gynaecologist was normal. Right
upper limb examination was negative for any soft tissue or
skeletal injuries. There were no signs of cellulitis, ery-
thema or blisters. Palpation of the soft tissues was non
tender, with no signs of grimacing or withdrawl and con-
sistency was soft with no signs of compartment syndrome.
Active movements at shoulder, elbow and wrist joints
were within normal range and painless. All peripheral
pulsations were normal with satisfactory capillary circula-
tion.
The laboratory parameters following admission have
been summarised in table 1. The C -reactive protein
[CRP], urea, creatinine and leucocyte count were elevated.
Arterial blood gas analysis was consistent with metabolic
acidosis. Chest X-ray and CT scan of the abdomen were
normal. Blood sample for Polymerised Chain Reaction
[PCR] test for meningococcal antigen was negative. Lum-
bar puncture examination was normal. Synacthen stimu-
lation test revealed a high baseline reading which was
suggestive of maximal stimulation. A provisional diagno-
sis of meningococcal septicaemia was made and on
microbiological advice treatment was commenced with a
third generation cephalosporin and teicoplanin by intra-
venous route. Vital parameters were supported with intra-
venous fluids and oxygen therapy by mask. Intake output
chart was strictly maintained.
Eight hours later her GCS dropped to 7 and in view of her
threatened airway, she was transferred to the intensive
care unit. She was further resuscitated, intubated, and ven-
tilated. 'Sepsis care bundle' was commenced [1] which
included optimisation of arterial pressure, haematocrit,
central venous pressure and mixed venous saturation [2],
low dose hydrocortisone administration following the
synacthen test [3], intensive insulin therapy [4], and low
tidal volume ventilation[5]. Renal replacement therapy by
veno-venous filtration was begun because of the worsen-
Table 1: Haematology and biochemical parameters, from admission to discharge
Date D a y  1 , D a y  2D a y  3D a y  3D a y  3D a y  4D a y  5D a y  5D a y  6D a y  7
Time 18.13 hrs 07 20 hrs 05 00 hrs 16 00 hrs 19 45 hrs 00 15 hrs 06 00 hrs 05 30 hrs 05 30 hrs 09 30 hrs
Haemoglobin 11.9 11.8 11.4 11 11.3 11.2 10.8 11.1 10.9 10.8
Leucocyte count 20.8 19.6 31.1 33.7 37.9 34.8 31.7 29.7 22.5 17.1
Platelets 151 130 90 90 94 86 86 108 156 281
Haematocrit 0.34 0.34 0.32 0.3 0.33 0.3 0.29 0.32 0.32 0.33
Prothrombin time 19 17.7 17.1 17.1 17.9 16.1 15.8 15.6 14.3 13.9
APTT 43.3 43.4 41 44.8 43.6 42.4 41.6 36.2 36 27.6
Fibrinogen 565 550 522 566 520 498 492 498 496 257
Na 132 138 134 134 134 134 135 137 143 136
K 3.1 4.1 4 3.9 3.9 3.8 3.4 4.1 4 3.6
HCO3 16 17 22 23 26 25 26 29 28 28
Chlorides 102 106 103 102 102 102 102 101 102 101
Urea 17.6 16.4 9.3 7.8 7.6 7 7.2 7.4 11.5 12
Creatinine 413 347 198 163 149 143 137 93 114 102
Glucose 9.3 8.5 7.7 7.2 7.4 7.4 7.4 5.7 6.6 6.5
Albumin 18 15 15 12 12 13 13 13 12 18
CRP 352 350 231 208 202 173 144 66 34.9 23.8
Magnesium 0.37 1.44 0.97 0.9 0.87 0.8 0.83 0.78 1.64 1.23
Phosphorus 0.5 1.1 0.8 0.6 1.2 0.7 0.8 0.9 1.1 1
Calcium 2.25 2.2 2.24 2.36 2.23 2.35 2.49 2.43 2.2 2.11
Lactate 3.7 1.9 1.4 1 1 1.1 1 1.2 1.1 1.1
Creatinine kinase 152 264 265 265 489 1428 3229 9367 5345 2123
Bilirubin 1 09 1 2 1 6 1 6 1 4 1 0979
ALT 50 33 35 37 28 44 55 58 111 113
AST 31 34 35 67 77 79 104 295 197 204
Globulin 39 35 36 35 36 36 36 34 34 34
Total proteins 58 50 48 47 49 48 47 47 49 55
* All parameters in SI units
APTT – Activated partial thromboplastin time
ALT – Alanine transaminase
AST – Asparatate transaminase
CRP – C-reactive protein
HCO3 – BicarbonateJournal of Medical Case Reports 2007, 1:118 http://www.jmedicalcasereports.com/content/1/1/118
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ing acidosis. Recombinant human protein C was not
given, as the criteria for its administration were not met
[6].
Over the next 18 hours a non-blanching erythematous
rash appeared over the right upper limb, which progressed
rapidly to a blister over the medial aspect of the arm with
gross swelling. There was no local rise of temperature and
the consistency was soft with satisfactory capillary circula-
tion [Fig 1]. A diagnosis of necrotising fasciitis was consid-
ered. X-ray of the arm revealed no bony injury and no gas
was evident in the subcutaneous tissues. The patient was
hypotensive, clinically unstable and required constant
monitoring and support. MRI was not available over the
weekend and it was decided to proceed further on clinical
assessment alone. Emergency surgery including the
option of an amputation or a disarticulation was consid-
ered.
On microbiological advice, the antibiotics were changed
to imipenem to cover both staphylococcal and streptococ-
cal infection and clindamycin for its improved soft tissue
penetration and ability to halt toxin production. Repeat
blood samples revealed an elevated white cell count and
CRP and normal coagulation parameters. Creatinine
kinase was high and urine was negative for myoglobin.
Initial blood cultures were negative and a repeat blood
culture at 48 hours following admission was positive for
alpha haemolytic (viridans) streptococcus mitis. The sep-
sis care bundle was continued, and the clinical and bio-
chemical picture were reviewed frequently by senior
orthopaedic, and intensive care staff.
The patient improved within the next 20 hours and she
was weaned from renal replacement therapy, ventilation
and was extubated. She was transferred to the ward after
24 hours for further management. Oral clindamycin was
continued for a further 2 weeks until her blood parame-
ters were optimised. The skin lesions disappeared over the
next three weeks with full recovery of her upper limb func-
tion [Fig 2].
Discussion
Streptococcal toxic shock syndrome is a distinct entity,
which is aggressive compared to the milder forms of strep-
tococcal infections such as pyomyositis and fasciitis [7].
Earlier cases of streptococcal myositis described in the lit-
erature indicate that the causative organism is streptococ-
cus pyogenes [7-14] and the condition presents with a
uniform pattern of involvement, with the lower limbs
more commonly involved [8,9]. A high index of suspicion
at the onset may present the only chance of survival in
these infections as the disease has mortality as high as 85
% [10,11]. This poor outcome is due in large part to the
non-specific features at presentation, leading to misdiag-
nosis or delayed diagnosis, the aggressive nature of infec-
tion which is frequently underestimated, and delay in
Day 10, post admission Figure 2
Day 10, post admission.
Day 3, post admission Figure 1
Day 3, post admission.Journal of Medical Case Reports 2007, 1:118 http://www.jmedicalcasereports.com/content/1/1/118
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appropriate administration of antibiotics and surgical
debridement [12]. Although many specific variations of
necrotising soft tissue infections have been described on
the basis of etiology, microbiology, and specific anatomic
location of the infection, the initial approach to the diag-
nosis, antimicrobial treatment, and decision to use opera-
tive management are similar for all forms and are more
important than determining the specific variant. [15]
The guidelines for management of severe sepsis and septic
shock have been developed [1]. In our patient a definitive
diagnosis could not be made until 34 hours after admis-
sion. The possible reasons for this delay could be the
vague history and non-specific clinical features, the
absence of a clinically detectable septic focus in a previ-
ously healthy patient and the time required for organisms
to be cultured in the laboratory. The patient was screened
for all the possible pathogens from vulnerable areas
including an MRSA screening and only the second blood
culture sample sent from the Intensive Care Unit was
reported positive for streptococcus mitis. The microbiol-
ogist was unsure of the clinical significance because of the
normal commensal behaviour of the organism. Neverthe-
less clindamycin therapy was initiated in addition to
teicoplanin. This highlights the importance of a persistent
diligent search for a possible focus with repeated clinical
examination and laboratory investigations in clinically
vague situations. The early institution of goal directed
therapy with sepsis care bundle probably led to a reduc-
tion in the bacterial toxin load and may have lessened the
degree of end organ damage. Nevertheless the patient had
impaired renal and hepatic function for seven days in the
recovery period.
When an orthopaedic opinion was sought the patient was
toxaemic and was on ventilatory support. A distinguishing
clinical feature of necrotising fasciitis is the wood-hard
feel of the subcutaneous tissues. The underlying tissues
are firm, and the fascial planes and muscle groups cannot
be discerned by palpation. It is often possible to observe a
broad erythematous tract in the skin along the route of the
infection as it advances cephalad in an extremity. If there
is an open wound, probing the edges with a blunt instru-
ment permits ready dissection of the superficial fascial
planes well beyond the wound margins [15]. In our
patient, the hard wooden feeling of the soft tissues was
characteristically absent. A positive blood culture, serial
high levels of creatinine kinase, and a negative urine test
for myoglobin along with the clinical features were highly
indicative for streptococcal myositis. MRI though useful
may not be possible in an unstable patient or may be una-
vailable for several reasons. Further, data regarding the
sensitivity and specificity of CT or MRI are unavailable,
and requesting such studies may delay definitive diagno-
sis and treatment. In practice, clinical judgment is the
most important element in diagnosis [15].
The diagnosis of compartment syndrome requires a high
degree of clinical judgement and is difficult in a ventilated
patient. Monitoring of pressure has no harmful effect and
may allow early fasciotomy, although the intracompart-
mental pressure threshold for such an undertaking is still
unclear [16]
The decision to undertake aggressive surgery should be
based on several considerations the commonest being
failure to respond to antimicrobial therapy [15]. In our
patient the option of a vigorous debridement including
amputation or a disarticulation was considered initially.
However on balance, the decision to operate was deferred
as there was clinical improvement in the next 12 hours. A
definitive tissue diagnosis of streptococcal mitis was there-
fore not possible.
Streptococcus mitis is an alpha haemolytic streptococcus
of the viridans group, normally a commensal in the oral
cavity and is known to cause endocarditis in patients with
damaged heart valves. It lacks the polysaccharide capsule
and antigenic protein which is typically present in the
pyogenic strains of streptococci [17,18]. Streptococcal
toxic shock syndrome has been reported to occur in
immunocompromised hosts with bone marrow trans-
plants due to alpha haemolytic (viridans) streptococcus
mitis [19].
Streptococcal toxic-shock syndrome is defined as any
group A streptococcal infection associated with the early
onset of shock and organ failure. The criteria for diagnosis
have been well described and are summarised in Table
2[20].
Streptococcal toxic shock syndrome caused by group A
streptococci should be treated with clindamycin and pen-
Table 2: Streptococcal Toxic Shock Syndrome
12
Criterion A Sterile site Non sterile body site
Criterion B Hypotension Clinical and laboratory abnormalities 
including renal impairment, Liver 
abnormalities, Acute respiratory 
distress syndrome, extensive tissue 
necrosis ie. Necrotising fascitis and 
erythematous rash (requires two 
or more for diagnosis)
Criterion A = Isolation of group A Streptococcus
Criterion B = Clinical signs of severity
Definite Case = A1 + B (1+2)
Probable Case = A2 + B (1+2)Journal of Medical Case Reports 2007, 1:118 http://www.jmedicalcasereports.com/content/1/1/118
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icillin. The rationale for clindamycin is based on in vitro
studies demonstrating both toxin suppression and modu-
lation of cytokine (i.e. TNF) production, on animal stud-
ies demonstrating superior efficacy compared to
penicillin, and on two observational studies demonstrat-
ing greater efficacy for clindamycin than for β-lactam anti-
biotics [20,21]. It has also been suggested that in vitro
sensitivity of group A haemolytic streptococci to penicillin
may not be effective in vivo [22] and clindamycin may be
more efficacious but has declining efficacy if treatment is
delayed [22,23].
Anecdotal evidence suggests that intravenous immu-
noglobulin [IVIG] may have a place in neutralising the
secreted streptococcal toxins that are thought to mediate
features of the disease [24]. The use of a medical regimen
including IVIG in patients with severe Group A Strepto-
coccal soft tissue infections may allow an initial non-oper-
ative or minimally invasive approach which can limit the
need to perform immediate wide debridements and
amputations in unstable patients [25]. However a recom-
mendation on the use of IVIG to treat streptococcal toxic
shock syndrome cannot be made with certainty. Although
there is ample evidence for the role of extracellular strep-
tococcal toxins in shock, organ failure, and tissue destruc-
tion, different batches of IVIG contain variable quantities
of neutralising antibodies to some of these toxins and
definitive clinical data are lacking [26].
Other case reports of streptococcal toxic shock syndrome
with streptococcus pyogenes report high patient mortality
despite aggressive surgical debridement. Early diagnosis
and aggressive supportive treatment may alter the final
outcome favourably [8,11,12]. This probably is true and
as in our patient may result in better outcomes with strep-
tococcus mitis infections.
Conclusion
Streptococcal toxic shock syndrome due to alpha-haemo-
lytic [viridians] streptococcus mitis infection in a previ-
ously healthy person is possible and can present as a life
or limb-threatening emergency. This needs early recogni-
tion and successful outcome is possible by maintaining a
high index of suspicion, early diagnosis and aggressive
organ support.
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